[go: up one dir, main page]

AU2001256727A1 - Preventive or therapeutic drugs for cancers containing cyanidin compounds as theactive ingredient - Google Patents

Preventive or therapeutic drugs for cancers containing cyanidin compounds as theactive ingredient

Info

Publication number
AU2001256727A1
AU2001256727A1 AU2001256727A AU5672701A AU2001256727A1 AU 2001256727 A1 AU2001256727 A1 AU 2001256727A1 AU 2001256727 A AU2001256727 A AU 2001256727A AU 5672701 A AU5672701 A AU 5672701A AU 2001256727 A1 AU2001256727 A1 AU 2001256727A1
Authority
AU
Australia
Prior art keywords
preventive
therapeutic drugs
cancers containing
containing cyanidin
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001256727A
Inventor
Akihiro Hagiwara
Katsumi Imaida
Takatoshi Koda
Mikio Nakamura
Tomoyuki Shirai
Seiko Tamano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
San Ei Gen FFI Inc
Original Assignee
Inc San Ei Gen F F I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inc San Ei Gen F F I filed Critical Inc San Ei Gen F F I
Publication of AU2001256727A1 publication Critical patent/AU2001256727A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof containing fruit or vegetable juices
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
    • C07D311/62—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06—Benzopyran radicals
    • C07H17/065—Benzo[b]pyrans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Confectionery (AREA)
  • Non-Alcoholic Beverages (AREA)

Abstract

According to the present invention, provided is a preventive or therapeutic agent for cancer containing a cyanidin compound of the general formula (I): <CHEM> Äwherein R is selected from the group consisting of H, - beta -D-glucopyranoside and -6-malonyl- beta -D- glucopyranosideÜ as an active ingredient. Since the cyanidin compound is naturally contained in various plants, prevention or treatment of cancer can be carried out safely and effectively by using the above-described agent.
AU2001256727A 2000-08-11 2001-05-14 Preventive or therapeutic drugs for cancers containing cyanidin compounds as theactive ingredient Abandoned AU2001256727A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-245165 2000-08-11
JP2000245165A JP2002053468A (en) 2000-08-11 2000-08-11 Cancer prophylactic or therapeutic agent containing cyanidin compound as active ingredient
PCT/JP2001/004001 WO2002013836A1 (en) 2000-08-11 2001-05-14 Preventive or therapeutic drugs for cancers containing cyanidin compounds as the active ingredient

Publications (1)

Publication Number Publication Date
AU2001256727A1 true AU2001256727A1 (en) 2002-02-25

Family

ID=18735739

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001256727A Abandoned AU2001256727A1 (en) 2000-08-11 2001-05-14 Preventive or therapeutic drugs for cancers containing cyanidin compounds as theactive ingredient

Country Status (7)

Country Link
EP (1) EP1325748B1 (en)
JP (1) JP2002053468A (en)
AT (1) ATE332697T1 (en)
AU (1) AU2001256727A1 (en)
CA (1) CA2417845A1 (en)
DE (1) DE60121459T2 (en)
WO (1) WO2002013836A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003064538A1 (en) * 2002-02-01 2003-08-07 San-Ei Gen F.F.I., Inc. Purified purple corn color and method of preparing the same
EP1617837A4 (en) 2003-04-04 2008-08-06 Tg Biotech Corp COMPOSITION FOR THE PREVENTION AND TREATMENT OF ALLERGIC DISEASES, COMPRISING A BLACK RICE EXTRACT AND THE THERAPEUTIC USE THEREOF
US7863248B2 (en) 2003-10-30 2011-01-04 Meiji Seika Kaisha, Ltd. Tyrosinase activity inhibitor and ameliorant for facial blood flow
JP5201662B2 (en) * 2007-02-28 2013-06-05 キッコーマン株式会社 Blood flow improving composition
RU2349311C1 (en) * 2007-08-02 2009-03-20 Михаил Владимирович Кутушов Application of naphthalene derivative as oncological disease treatment medicine
JP2013100272A (en) * 2011-10-17 2013-05-23 Kao Corp Srf signal activating agent
CN103609808B (en) * 2013-10-22 2015-08-19 界首市兆龙食品有限公司 Rich selenium sand mold toffee
KR101644997B1 (en) 2014-06-09 2016-08-03 롯데제과주식회사 Method for manufacturing tablet containing cocoa powder and tablet by the same
JP6364362B2 (en) * 2015-02-17 2018-07-25 学校法人福岡大学 Human chymase inhibitor and functional food, and method for inhibiting human chymase activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1073461A (en) * 1992-11-09 1993-06-23 青岛海洋大学 Process for extracting purple corn pigment
AU2578997A (en) * 1996-04-17 1997-11-19 Unifob Use of anthocyanidin and anthocyanidin derivatives
JP2000178295A (en) * 1998-12-17 2000-06-27 Lion Corp Antitumor composition

Also Published As

Publication number Publication date
DE60121459D1 (en) 2006-08-24
EP1325748A1 (en) 2003-07-09
DE60121459T2 (en) 2007-02-15
CA2417845A1 (en) 2003-01-30
ATE332697T1 (en) 2006-08-15
WO2002013836A1 (en) 2002-02-21
EP1325748B1 (en) 2006-07-12
JP2002053468A (en) 2002-02-19
EP1325748A4 (en) 2005-01-26

Similar Documents

Publication Publication Date Title
IL205420A (en) Immunoregulatory compounds and derivatives, pharmaceutical compositions and use thereof in treating inflammatory conditions of the gastrointestinal tract
MY141661A (en) 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
WO1999063826A3 (en) Agents for combating plant pests
WO2002076472A3 (en) Pharmaceutical combinations for the treatment of cancer comprising dioxolane nucleoside analogs
MXPA04012965A (en) Viral inhibitors.
BR0002936A (en) Bicycliccarbonyl-indole compounds as anti-inflammatory / analgesic agents
AU2246292A (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
MD2447F2 (en) Pharmaceutical composition, use thereof and methods of treatment of cephalalgia, migraine, sickness and vomiting
SI1664041T1 (en) Phenyl-carboxamide compounds useful for treating pain
MY128014A (en) Thiol and thiocarbonyl derivatives which are useful as carboxypeptidase u inhibitors
PL359415A1 (en) Oxadiazole derivatives having anticancer effects
AU2001256727A1 (en) Preventive or therapeutic drugs for cancers containing cyanidin compounds as theactive ingredient
IL159412A0 (en) A synergistic pharmaceutical combination for the prevention or treatment of diabetes
WO2003101382A3 (en) Compounds useful in the treatment of anthrax and inhibiting lethal factor
PL328198A1 (en) Antiasthmatic therapeutic agents containing organic selenium compounds
WO2001007029A3 (en) Substituted guanidines and the use thereof
WO2003095453A1 (en) Compounds against helicobacter activity
MXPA99003849A (en) 9a,11b-dehydro derivatives of 9-oxime-3-keto-6-0-methylerythromycin.
AU4485101A (en) Antiviral therapy
GEP20053513B (en) 2-Aminocarbonyl-9H-Purine Derivatives
IL150181A0 (en) Quaternary ammonnium and their-tussive agent